Latest-Generation Drug Eluting and Bioabsorbable Stents

Authors

  • Eleftherios Tsiamis First Department of Cardiology, Ippokratio University Hospital, Athens, Greece

DOI:

https://doi.org/10.2015/hc.v9i1%20Sup.664

Keywords:

coronary angioplasty, coronary stent, bioabsorbable stent, acute coronary syndrome

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) was introduced in the late 1970s as an alternative to coronary artery bypass graft surgery for coronary revascularization; since then, it has been accepted as a safe, reliable, and effective treatment for coronary artery disease, and its use has spread worldwide.

Downloads

Published

2014-06-02

Issue

Vol. 9 No. 1 Sup (2014): ATHENS CARDIOLOGY UPDATE 2014

Section

ATHENS CARDIOLOGY UPDATE 2014

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).